Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Bellevue Funds Lux - BB Biotech

+ Add to Watchlist

M0U2:GR

498.3700 EUR 5.7870 1.15%

As of 13:39:06 ET on 04/17/2015.

Snapshot for Bellevue Funds Lux - BB Biotech (M0U2)

Open: 510.0200 High - Low: 510.0200 - 498.3700 Primary Exchange: Frankfurt
Volume: 0 52-Week Range: 226.6200 - 530.2600 Beta vs DAX: 0.7170

ETF Chart for M0U2

No chart data available.
  • M0U2:GR 504.2880
  • 1D
  • 1M
  • 1Y
504.1570
Interactive M0U2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for M0U2

Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.

Inception Date: 2009-03-31 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER
Web Site: www.bellevuegroup.com

Fundamentals for M0U2

NAV -
Assets (M) (on 2015-04-15) 106.7877
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for M0U2

No dividends reported

Performance for M0U2

1-Month -2.86% 1-Year +113.69%
3-Month +21.08% 3-Year +54.35%
Year To Date +32.68% 5-Year +31.69%
Expense Ratio -

Top Fund Holdings for M0U2

Filing Date: 03/31/2015
Name Position Value % of Total
Biogen Inc 20,000 8,444,800 8.356%
Celgene Corp 63,000 7,262,640 7.186%
Gilead Sciences Inc 72,000 7,065,360 6.991%
Amgen Inc 30,866 4,933,930 4.882%
Alexion Pharmaceuticals Inc 20,746 3,595,282 3.557%
Regeneron Pharmaceuticals Inc 7,595 3,428,991 3.393%
Vertex Pharmaceuticals Inc 28,500 3,362,145 3.327%
Mylan NV 55,000 3,264,250 3.230%
Medivation Inc 24,300 3,136,401 3.103%
BioMarin Pharmaceutical Inc 25,000 3,115,500 3.083%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil